Breaking
Loading breaking news...
Loading...
Northeast Herald Logo

3.2 magnitude earthquake hits Assam, no damage reported

Guwahati/UNI: A mild intensity earthquake, measuring 3.2 magnitudes on the Richter Scale, hit Hojai town in Assam Monday.

IBNS
5 min read
3.2 magnitude earthquake hits Assam, no damage reported
Share this article:

The earthquake occurred at 11:57 am, the National Centre for Seismology confirmed in a report.

No loss of life or damage to property was reported in the incident.

The quake occurred at a depth of 10 km, the report said.

Tags:
#agartala news#tripura news#northeast herald#news news

IBNS

Senior Staff Reporter at Northeast Herald, covering news from Tripura and Northeast India.

Related Articles

CK Birla Hospitals launches massive cervical cancer fight: 5,000 women set to receive life-saving HPV vaccine!

CK Birla Hospitals launches massive cervical cancer fight: 5,000 women set to receive life-saving HPV vaccine!

Kolkata/IBNS: In line with its commitment to the #FightAgainstCervicalCancer, CK Birla Hospitals has intensified its cervical cancer vaccination drive, with an initial aim of administering 5,000 Human Papillomavirus (HPV) vaccines.

IBNSDec 09
Want to exercise more? Study says the secret starts with your sleep

Want to exercise more? Study says the secret starts with your sleep

Getting enough sleep and staying active are two of the most important things we can do for our health, but new research shows that most people struggle to achieve both, and that sleep may hold the key to moving more.

IBNSDec 09
India gears up for a global health showdown as 2nd WHO Traditional Medicine Summit Nears!

India gears up for a global health showdown as 2nd WHO Traditional Medicine Summit Nears!

The Ministry of Ayush on Monday organized a Curtain Raiser Press Conference at the National Media Centre, New Delhi, ahead of the 2nd WHO Global Summit on Traditional Medicine, to be held from December 17–19 at Bharat Mandapam, New Delhi, where representatives of 100 countries are expected to attend.

IBNSDec 08
Baldness battle may be over: New drug shows stunning results in phase III trial

Baldness battle may be over: New drug shows stunning results in phase III trial

Cosmo Pharmaceuticals N.V, an AI-powered healthcare and speciality pharma,  has announced a compelling topline results from its two pivotal Phase III trials of clascoterone 5% topical solution for male androgenetic alopecia (AGA, also known as male-pattern hair loss), marking a potential first major therapeutic breakthrough in hair-loss treatment in more than three decades.

IBNSDec 08